Keziah is a Torres Strait Islander woman and Director of Guunu-maana (Heal) Aboriginal and Torres Strait Islander Health Program at The George Institute for Global Health. Keziah is a Future Women Emerging Leader, and sits on the Association of Australian Medical Research Institute's Gender, Equity, Diversity and Inclusion committee. Keziah chairs the George Institute's Global Research and Impact Committee and has chaired the Research Committee for Aboriginal and Torres Strait Islander Health since 2017. She leads the development and implementation of Aboriginal and Torres Strait Islander health research strategy, policy, stakeholder partnerships and Indigenous research coordination within a global research institute.

Keziah has extensive experience in social and cultural determinants of health, Indigenous methodologies, and knowledge translation and impact measurement that privilege Indigenous knowledges, as well as applying decolonising methods to organisation and systems change. Keziah is a recognised leader in implementation of strategic organisational activities to increase cultural safety and capability within global health research.

A/Prof Laura Downey leads The George Institute’s global program for Universal Health Coverage (UHC). She is a conjoint Associate Professor in health economics and policy in the School of Population Health at UNSW, and an Advanced Research Fellow in the School of Public Health at Imperial College London, UK.

Dr Downey's research is focused broadly on evaluating health system performance in relation to UHC goals, and developing innovative solutions to support equitable access to high quality, affordable care for the world's most at-risk populations. She is a passionate advocate for health equity, and in particular gender equity, where she uses data to champion greater visibility of women's health issues and more inclusive and participatory evidence to policy processes. She is a Senior Investigator and the Capacity Strengthening co-lead of a £10million NIHR Global Health Research Centre for Non-Communicable Diseases and Environmental Change, where her research focuses on community-driven multisectoral intervention design, delivery, and evaluation to strengthen health systems to protect populations in India, Indonesia, and Bangladesh from environmental issues such as extreme heat and air pollution. She is an active invited advisor to the World Health Organisation (WHO) and currently a member of the WHO advisory group for the use of Glucagon-like Peptide Receptor Agonists (GLP1-RAs) for the management of obesity. She was an invited expert member of the Health Economics advisory group to the UK Infected Blood Inquiry (2020-2024), whose work directly informed recommendations made by the Inquiry Chair to the UK Government on behalf of the tens of thousands of individuals who were infected with HIV and Hepatitis A, B, and C by the National Health Service. She was an advisor to the Indian federal government between 2015 -2019 to support the establishment of a core Health Technology Assessment (HTA) function within the Ministry of Health and Family Welfare and remains an active advisor to the Indian Institute of Public Health, the Indian Council of Medical Research, and numerous State governments across India.

Dr Downey has active research collaborators across Asia, Africa, and Europe and has worked in partnership with global institutions such as the World Health Organisation, the Bill and Melinda Gates Foundation, The Asian Development Bank, and the World Bank. She has held previous positions with the National Institute of Health and Care Excellence (NICE) UK, the Centre for Global Development Europe, and University College London.

Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.

Anthony Sunjaya is a medical doctor from Indonesia and Honorary Fellow at the Respiratory and Health Systems Division, The George Institute for Global Health, UNSW Sydney, Australia. He is also an Honorary Research Fellow at the School of Public Health, Imperial College London and a Visiting Researcher at the Royal Brompton and Harefield Hospitals.

His research focuses on cardiorespiratory diseases, complex chronic diseases, primary care, and digital health especially the development, validation and translation of decision support systems, AI, and virtual care. He has a special interest in supporting universal health coverage, improving care, especially in low-resource settings and primary care through the use of innovative evidence-based solutions.

He is Chief Investigator of the Breathlessness Rapid Evaluation and THErapy (BREATHE) trial funded by the Australian Government Medical Research Future Fund to optimise the assessment and management of chronic breathlessness in primary care through implementation of a clinical decision support system for breathlessness across 40 GP practices in Australia building upon work during his PhD which was supported by the UNSW Scientia PhD program.

He is currently Chair, Primary Care SIG, Thoracic Society of Australia and New Zealand (TSANZ); Chair, Membership Committee, Society of Medical Decision Making (SMDM); Vice-Chair of the Digital Transformation Leadership working group in the International Society for Telemedicine and e-Health (ISfTeH), and Editorial Advisory Board member of the Annals of Family Medicine. He is also an active social entrepreneur and co-founder of BantingMed, a diabetes digital health startup.

He was previously President of Postgraduate Council UNSW and ASEAN Society UNSW, a delegate to the 2023 Group of 7 Youth Summit in Japan and has contributed to reports for the World Health Organization and Asthma Australia.

After completion of her Masters, Sudha started her career in clinical research at Clinigene International Ltd, sister concerns of Biocon. She has worked in clinical research industry for the past five and a half years and was part of George Clinical for nearly four years.

Sudha has had experience in working on academic trials and seeks to pursue higher education and training in public health research, especially in the areas of non-communicable diseases including mental health and injuries.

She is currently involved in a study where mobile-based technology is being used to provide basic mental health care to scheduled tribe villages in rural Andhra Pradesh. 

Pallab leads Research department at The George Institute for Global Health, India. He trained as a psychiatrist at All India Institute of Medical Sciences, New Delhi, received training in public health at the London School of Hygiene and Tropical Medicine, as well as Johns Hopkins School of Public Health where he pursued his Masters and Doctoral training, respectively.

Professor Maulik has worked with the World Health Organisation (WHO), Geneva on Project Atlas and other mental health programs, and clinically as a psychiatrist in India and Australia. He has worked for more than 25 years in global mental health and has research network across multiple countries and institutions where he is affiliated with and with whom he collaborates on many projects.  

His particular research interests include social determinants of health, especially mental health services, mental disorders, international mental health, and intellectual disability. He is a Principal Investigator or co-investigator on many large mental health projects in India and abroad. He primarily focuses on delivering affordable and accessible mental health care for disadvantaged and marginalized communities in India, while using technology-enabled solutions to enable the health system to function more efficiently. He also leads a significant programme of work on stigma related to mental health. He was an Intermediate Career Wellcome Trust/DBT India Alliance Fellow from 2014-19 and currently is a Senior Fellow of the Wellcome Trust/DBT India Alliance.

Maree is responsible for designing, leading, and delivering a distinctive and vibrant postgraduate, postdoctoral and future leader research experience at The George. Maree and her team provide management and oversight of ‘higher degree by research’ candidates, their supervisors, visiting fellows and work with the training team to co-ordinate postgraduate research training.

Maree also leads a program of research focusing on developing simple, cost-effective strategies to prevent depression and significantly improve the outcome for people with chronic disease.

Maree works one day per week as a Professor of Epidemiology in the Faculty of Health and Wellbeing at The University of Central Lancashire in the United Kingdom.